Products

OncoStudio (OS-01)
OncoSoft. Co.
Oncology AI
OncoStudio by OncoSoft. Co. is an AI-powered auto-contouring software for radiation oncology that transforms hours of manual organ segmentation into minutes with clinical-grade precision, streamlining treatment planning workflows.

See all 1 product →

About OncoSoft.

OncoSoft is a pioneering medical technology company that specializes in developing advanced artificial intelligence (AI) software solutions for radiation oncology. Their primary goal is to enhance the precision and efficiency of cancer treatment by streamlining the workflows of radiation oncologists. The company’s flagship product, OncoStudio, utilizes deep learning to automate critical and time-consuming tasks in radiation therapy, such as treatment site detection and organ contour generation. This automation significantly reduces the manual effort involved in outlining tumors and organs, transforming hours of work into minutes of accurate segmentation, and allowing clinicians to dedicate more time to patient care.

OncoSoft’s solutions are designed to be universally compatible with existing hardware and software, adhering to global standards like DICOM and HL7 FHIR, ensuring seamless integration into clinical environments. Beyond OncoStudio, OncoSoft is expanding its offerings with modules like OncoFlow for workflow management, and the in-development OncoPlan for treatment planning and OncoRPT for radiopharmaceutical therapy workflow management. These integrated platforms aim to unify the entire radiation therapy workflow, from diagnosis through follow-up, by automating complex, repetitive tasks and ensuring continuous, secure information flow across departments. OncoSoft is committed to continuous innovation, collaborating with clinical experts and incorporating user feedback to refine its products and provide tailored solutions that meet the specific needs of healthcare institutions.

Focus Areas

AI-driven radiation therapy medical imaging analysis oncology auto-contouring workflow management treatment planning deep learning

Business Intelligence

TechnologyCloud-based platform, Deep Learning, AI operating system (OncoAgent), C++ and Qt framework for OncoStudio 2.0, integrates with VTK, ITK, and DCMTK libraries, utilizes Large Language Models (LLMs)

What Physicians Need to Know

AI-based Radiation Therapy
OncoSoft specializes in AI-driven radiation therapy solutions, aiming to improve treatment planning and clinical decision support. Their technology helps healthcare professionals manage complex radiation treatment workflows with greater efficiency and analytical support. They are developing an all-in-one radiation therapy platform that encompasses treatment planning, analysis, and reporting.
Auto-Contouring
OncoSoft's flagship product, OncoStudio, is an AI-powered auto-contouring solution that automates critical tasks like treatment site detection and organ contour generation. It supports over 400 structures and Regions of Interest (ROIs) across CT and MR imaging for various anatomical locations, including the head & neck, thorax, abdomen, and pelvis. OncoStudio has been proven in practice with over 20 million contours in treatments for 300,000 patients. The AI-generated contours show high geometric similarity to manually drawn contours, making them suitable for prostate cancer treatment planning.
Workflow Management
OncoFlow, OncoSoft's workflow management software, optimizes the patient journey through seamless integration, intelligent automation, and enhanced collaboration. It acts as a central nervous system for radiation therapy, unifying data and workflows across departments in real-time and automating tasks to reduce manual effort by 75%.
Treatment Planning
OncoSoft is developing OncoPlan, a treatment planning system built around OncoAgent, an agentic AI for radiation oncology. This system aims to automate complex, repetitive tasks and ensure secure, continuous information flow across departments. OncoSoft's AI-based tumor contouring technology has shown to increase the accuracy of radiation therapy by up to 2.36 times.
Radiopharmaceutical Therapy
OncoSoft has a roadmap that includes OncoRPT for precision dosimetry in radiopharmaceutical therapy, aiming to advance highly personalized cancer care. They are actively pursuing support for radiopharmaceutical therapy workflows.
Medical Image Analysis
OncoSoft specializes in AI-based image analysis software for radiation oncology. Their OncoStudio 2.0 software delivers real-time visualization of high-resolution 3D medical images. They support multimodal imaging and image fusion within integrated contouring and analysis workflows.
Oncology Informatics
OncoSoft offers an Oncology Information Management Solution (OIMS) designed to support multidisciplinary teams in cancer patient care. Their solutions provide clinical decision support, improve information transfer between departments, and generate analytical reports for decision-making and research.
Physician Tip

OncoSoft's OncoStudio offers rapid and accurate AI auto-contouring, significantly reducing the time spent on manual delineation and improving consistency in radiotherapy planning. The system's ability to process high-resolution 3D medical images in real-time and its intuitive user interface enhance efficiency. Physicians can benefit from the clinical decision support features, automated workflow management, and comprehensive quality assurance tools that aim to improve patient safety and treatment outcomes. The integration of Large Language Models (LLMs) and advanced AI for tumor contouring, in addition to organs at risk, expands the scope of automated treatment planning. OncoSoft's vendor-neutral platform allows for integration with existing hardware and software, minimizing disruption to current clinical ecosystems.

OncoSoft's OncoStudio is designed to be universally compatible with all commercially available hardware and software, adhering to global standards like DICOM and HL7 FHIR. OncoFlow integrates with TPS, R&V, and OIS systems, offering vendor-neutral integration to connect various equipment and software regardless of the manufacturer. OncoStudio 2.0 is developed as a CMake-based C++ and Qt application, integrating with major open-source libraries such as VTK, ITK, and DCMTK. The company is actively pursuing integration with external treatment planning systems (TPS) and support for radiopharmaceutical therapy workflows.

Products by OncoSoft.

1 product in the directory

OncoStudio (OS-01)
OncoSoft. Co.
Oncology AI
OncoStudio by OncoSoft. Co. is an AI-powered auto-contouring software for radiation oncology that transforms hours of manual organ segmentation into minutes with clinical-grade precision, streamlining treatment planning workflows.

What the Web Says

OncoSoft, also referred to as OncoEMR and Onco360 in some reviews, appears to be a company specializing in oncology software solutions, particularly AI-powered radiotherapy tools like OncoStudio and workflow management systems like OncoFlow. Product reviews highlight ease of use for patient tracking and treatment planning, but also mention issues with freezing, slow performance, and a non-user-friendly display for lab results. Employer reviews are mixed, with some praising a positive culture and work-life balance, while others criticize management, training, and a highly metrics-driven environment.

Overall: Mixed

Strengths

  • Easy to find and track patients.
  • Good for creating treatment plans and tracking patient progress.
  • Streamlines workflow and automates administrative tasks, improving efficiency and reducing costs.
  • Provides clinical decision support and improves data reporting.
  • OncoStudio offers fully automatic, fast, and accurate AI auto-contouring for radiotherapy.
  • Positive work environment, supportive team, and good work-life balance (mentioned in some employer reviews).

Limitations

  • Software can freeze and be slow.
  • Lab results display is not user-friendly and tracking specialty labs can be difficult.
  • Not always user-friendly for providers to document adequately and may require too many clicks.
  • May not work well with Apple products.
  • Poor training, highly metrics-driven, and unsupportive supervision (mentioned in some employer reviews).
  • Management issues and resistance to technological innovation (mentioned in some employer reviews).

Based on reviews from: G2, Capterra, oncosoft.io, oncosoft.com, qt.io, dlinrt.eu, Indeed.com

Last updated: 2026-10-27

Videos

News, demos, and interviews about OncoSoft..

Loading videos...

Videos load interactively. If none appear, search YouTube for OncoSoft. →

View all on YouTube

Press & Coverage

Oncosoft Official Blog
Oncosoft AI Radiotherapy Solution Obtains U.S. FDA 510(k) Clearance
Oncosoft announced that its AI-based automatic contouring solution 'OncoStudio' obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA), marking a significant milestone for commercialization in the U.S. market.
2025-03
Oncosoft Official Blog
Oncosoft Signs Solution Supply Agreement with Mayo Clinic, First Sales in U.S. Market
Oncosoft signed a solution supply agreement with Mayo Clinic Florida, introducing 10 licenses of 'OncoStudio' and 'OncoFlow', signifying its first sales in the U.S. market and global recognition of its technology.
2025-03
Qt Group
Oncosoft, a Korean medical AI startup, specializes in AI-based image analysis software for radiation oncology.
This article details Oncosoft's collaboration with Qt Group to enhance its OncoStudio 2.0 software, enabling real-time visualization of high-resolution 3D medical images and improving development productivity.
unknown
National Institutes of Health (NIH)
OncoStudio: An AI-Powered Auto-Segmentation Tool for Organs at Risk in Korean Patients Undergoing Radiotherapy
A study published by NIH concluded that OncoStudio, tailored for Korean patients, demonstrated superior segmentation accuracy across multiple anatomical regions, suggesting its suitability for radiotherapy planning in this population.
2024-10
Oncosoft Official Blog
'Radiation therapy AI' company Oncosoft raises $8.03 million Series B funding
Oncosoft announced the finalization of its Series B investment of $8.03 million, led by existing investors and joined by new ones, with funds aimed at developing next-generation healthcare AI solutions and global market expansion.
2024-09
Oncosoft Official Blog
Oncosoft Develops AI-based Tumor Contouring Technology with 2.36 Times Higher Accuracy
Oncosoft announced the development of an AI-based tumor contouring technology that increases the accuracy of radiation therapy by 2.36 times, achieved through collaboration with Yonsei Cancer Hospital and Massachusetts General Hospital.
2024-11
Oncosoft Newsletter
Oncosoft Selected for Government-Backed 'Global Collaborative R&D' Project to Initiate Next-Gen Multimodal AI Development with Harvard's Mass General Brigham
Oncosoft has been selected as the lead organization for a government-funded R&D project to advance next-generation medical AI, combining large language models with 3D medical imaging for high-precision tumor segmentation.
unknown
Medical Tech Outlook
Oncosoft: The Unified Platform for Streamlined Radiation Oncology Workflows
Medical Tech Outlook recognized Oncosoft as the 'Top AI Driven Radiation Therapy Solution in APAC 2025' for its vendor-neutral platform that unifies the entire radiation therapy workflow.
unknown

Frequently Asked Questions

OncoSoft offers OncoStudio, an AI-powered auto-contouring solution that automates treatment site detection and organ contour generation, significantly enhancing the efficiency and accuracy of radiation therapy planning. They also provide OncoFlow, a workflow management solution that integrates the entire radiation therapy process, from initial imaging to treatment, to reduce errors and streamline operations. OncoSoft is also developing OncoPlan for AI-driven treatment planning, including for particle therapy, and OncoRPT for radiopharmaceutical therapy.
OncoSoft's OncoStudio utilizes deep learning to achieve over 90% accuracy for organs at risk (OARs) and has been validated in clinical use. It has received 510(k) clearance from the U.S. FDA and medical device certifications in South Korea, Japan, Singapore, and Brazil, ensuring its safety and effectiveness.
OncoSoft's platform is vendor-neutral and designed for flexible integration with existing Picture Archiving and Communication Systems (PACS), Treatment Planning Systems (TPS), Electronic Medical Records (EMR), and therapy machines, adhering to international standards like DICOM and HL7. They have also obtained ISO/IEC 27001 & 27701 Certification for Information Security and Privacy Management Systems.
OncoSoft utilizes a subscription-based pricing model to make its advanced radiation oncology tools accessible and scalable for hospitals. They offer 24/7 support for technical, physics, and clinical issues through the Oncosoft Center, along with remote desktop support, help manuals, and software upgrades for customers with an Annual Maintenance Contract.
OncoSoft is a privately held medical technology company founded in 2019. They have secured Series A and Series B funding rounds and have established partnerships with institutions like the Mayo Clinic, which adopted OncoStudio and OncoFlow. Their solutions are currently implemented in over 100 hospitals worldwide.

Related Companies

SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]

NTL Healthcare is a South Korean AI-powered women’s health company specializing in cervical cancer screening and diagnostics. The company has a history dating back to 1996 when it first introduced an analog cervical cancer reading system, Cervicography, to Korea. Since then, NTL Healthcare has evolved its technology, developing the world’s first remote uterine cervical cancer […]

Lumonus is a healthcare technology company that specializes in AI-powered solutions for cancer care, particularly in radiation oncology. The company’s core offering is the Lumonus AI platform, a digital oncology system with AI-native clinical infrastructure designed to automate and orchestrate critical oncology workflows. This platform aims to enhance the quality and speed of care delivery […]

Deep Bio is a healthcare AI company that develops deep learning-based cancer diagnostic support software, aiming to advance patient outcomes by empowering clinicians with innovative technology. Their mission is to provide tools that enable medical professionals to make critical decisions, ultimately enhancing healthcare delivery and allowing clinicians to focus more on patient care. The company’s […]

AIRA Matrix is a healthcare AI company that develops cutting-edge artificial intelligence solutions for life sciences applications, with a strong emphasis on deep learning for medical image analysis. Their innovative products and services are designed to enhance diagnostic accuracy, improve workflow efficiency, and reduce turnaround times in pathology laboratories. The company provides diagnostic, prognostic, and […]

Surgical Reality is a healthcare AI company that specializes in advanced AI-powered 3D medical imaging and surgical planning software for thoracic surgery. Their core product, the Surgical Reality Viewer, converts standard CT scans into high-fidelity, patient-specific 3D models of the entire lung within minutes. This technology is designed to assist trained healthcare professionals with preoperative […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.